Microba Life Sciences Limited (ASX:MAP)
Australia · Delayed Price · Currency is AUD 0.0550
0.00 (0.00%)
Aug 28, 2026, 4:10 PM AEST
Microba Life Sciences Market Cap
Microba Life Sciences has a market cap or net worth of 39.44 million as of August 28, 2026. Its market cap has decreased by -31.82% in one year.
Market Cap
39.44M
Enterprise Value
30.71M
Revenue
14.90M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.06
ChartMarket Cap Chart
Since April 5, 2022, Microba Life Sciences's market cap has decreased from 96.03M to 39.44M, a decrease of -58.93%. That is a compound annual growth rate of -18.31%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 39.44M | -14.78% |
| Dec 31, 2025 | 46.28M | -47.00% |
| Dec 31, 2024 | 87.33M | 8.33% |
| Dec 29, 2023 | 80.61M | -29.31% |
| Dec 30, 2022 | 114.03M | 18.75% |
| Apr 5, 2022 | 96.03M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Australian Clinical Labs | 521.83M |
| Healius | 315.88M |
| Monash IVF Group | 261.06M |
| Cryosite | 61.01M |
| Rhythm Biosciences | 34.33M |
| INOVIQ | 26.04M |
| BCAL Diagnostics | 24.33M |
| ImExHS | 19.04M |